CN1132096A - Chinese drug for treatment of hemiplegia - Google Patents
Chinese drug for treatment of hemiplegia Download PDFInfo
- Publication number
- CN1132096A CN1132096A CN 95117933 CN95117933A CN1132096A CN 1132096 A CN1132096 A CN 1132096A CN 95117933 CN95117933 CN 95117933 CN 95117933 A CN95117933 A CN 95117933A CN 1132096 A CN1132096 A CN 1132096A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- hemiplegia
- medicine
- chinese patent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese patent medicine in the form of oral liquid for curing hemiplegia with 95% effective rate and less toxic by-effect is prepared from 20 Chinese-medicinal components such as astragalus root, uncaria stem with hooks, scorpion, rehmannia root, red peony root, musk, etc.
Description
The invention belongs to a kind of oral Chinese patent medicine for the treatment of the hemiplegia disease.
Hemiplegia is the sequela that cerebral thrombosis, cerebral hemorrhage, cerebral embolism etc. cause, this sick Therapeutic Method is different, middle in recent years medical circles are in conjunction with the experience of doctor family treatment hemiplegia in the present age, sum up acute stage to take stopgap measures, sequela stage is then based on the method for the treatment of both the principal and secondary aspects of a disease, the Therapeutic Principle adopts eliminating phlegm by purgation in the bowels, suppressing the hyperactive liver and subsiding YANG and promoting blood circulation to remove obstruction in the collateral, supplementing QI and nourishing YIN etc. respectively, and state's internal therapy primary disease effective percentage is about about 90% at present.
The present invention aims to provide the oral Chinese patent medicine compound recipe hemiplegia recovery ball of a kind of curative effect height, low price, treatment hemiplegia that toxic and side effects is little.
For achieving the above object, the raw material of Chinese medicine weight proportion following (wherein b is Unit Weight part) that the present invention adopts,
Radix Astragali 100-140b Ramulus Uncariae Cum Uncis 35-55b Scorpio 8-10b
Scolopendra 8-10b Radix Rehmanniae 24-30b Radix Paeoniae Rubra 16-20b
Radix Salviae Miltiorrhizae 65-85b Flos Carthami 24-30b Pheretima 27-33b
Flos Chrysanthemi 24-30b Rhizoma Gastrodiae 2-4b Poria 35-55b
Rhizoma Atractylodis Macrocephalae 16-20b Ramulus Mori 35-55b Radix Glycyrrhizae 16-20b
Fructus Corni 16-20b Rhizoma Dioscoreae 35-55b Cortex Moutan 16-20b
The orange 35-55b of Radix Scutellariae 7-11b
Moschus 0.0002-0.0004b
The raw material of Chinese medicine of said ratio is made oral administration pills.
Hemiplegia mainly is because of disorder of emotion or eating and drinking without temperance or prolonged illness overwork, cause the body imbalance between YIN and YANG, internal organs, meridians, QI and blood dysfunction, thus cause excessive rising of liver-YANG, attacking up head and eyes, or phlegm stagnating in meridian makes brain disturb wind, or the hepatic and renal YIN deficiency, brains wind are disturbed due to the head.
At above-mentioned Chinese medical discrimination, we reuse Radix Astragali QI invigorating, join Radix Paeoniae Rubra, Flos Carthami, the Radix Salviae Miltiorrhizae promoting the circulation of blood dissipating blood stasis of invigorating blood circulation, Scorpio, Scolopendra, the Pheretima dredge the meridian passage that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., Ramulus Uncariae Cum Uncis, Flos Chrysanthemi, Rhizoma Gastrodiae suppressing the hyperactive liver and subsiding YANG dispel the wind, the Rhizoma Atractylodis Macrocephalae, Poria, Ramulus Mori spleen invigorating eliminating dampness and dredging channels, Fructus Corni, Rhizoma Dioscoreae, Cortex Moutan nourishing the kidney and liver yin fluid astringing, Radix Scutellariae, orange heat clearing and damp drying are reduced phlegm, and the Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription is a messenger drug, help again with the sharp key refreshment of a little Moschus switch, and help other medicines performance effect.
We mix to add and subtract for sides such as BUYANG HUANWU TANG, phlegm-removing decoction, TIANMA GOUTENG YIN, LIUWEI DIHUANG TANG and form, and full side's compatibility has inrigorating qi and promoting blood circulation, the dissipating blood stasis that stimulates the menstrual flow, suppressing the hyperactive liver to relieve the wind syndrome, heat clearing away eliminate the phlegm, the effect of nourishing the kidney and liver, the refreshment of having one's ideas straightened out.
Take this medicine and can improve the blood vessel circulation, strengthen blood flow, reduce cerebral vascular resistance, anti-platelet aggregation cures mainly hemiplegia and sequela due to the cerebrovascular disease such as paralysis due to windstroke, hemiplegia, facial hemiparalysis, aphasia, aphasia or slurred speech, blurred vision, numb limbs and tense tendons, walking hardship, bones and muscles pain, contracture of the limbs.
According to 100 routine clinical treatment observations:
Male's 79 examples, women's 21 examples, maximum 76 years old, minimum 46 years old, average year made 61 years old.
The case choice criteria
1, primary symptom: hemiplegia, crooked mouth and tongue, the mind unconsciousness, stiff tongue or in silence, partially
The body numbness;
2, Acute onset;
3, sick sending out has inducement more, and premonitory symptom is arranged before not sending out more;
4, good sending out makes more than 40 years old in year;
Chinese medical discrimination
1, in through the knot: wind-phlegm class, deficiency of YIN liver-yang hyperactivity class
2, middle internal organs: close the disease class, take off the disease class, the sequela class
Curative effect is declared criterion
1, be almost recovered: conscious, language performance is normal, upper limb shoulder joint articulations digitorum manus
Movable normal, the lower limb toe joint is stretched and is bent freely, and life can be taken care of oneself.
2, produce effects: mind is gradually clear-headed, and language performance is general, upper limb shoulder joint, articulations digitorum manus
Can go up act and move respectively, but muscular strength is poor, lower limb can be raised more than 45 °, toe joint
Can stretch in the wrong, but a little less than the power.
3, effective: drowsy, after waking up can and people's words, speak that it is incomplete to express, last act less than
Shoulder can be clenched fist and be stretched finger, and lower limb can be balanced, and toe joint is slightly moving.
4, invalid: cardinal symptom does not have change.
Test method
1, compound recipe hemiplegia recovery ball is oral, every day secondary, each half ball.
2, inactive without exception other Chinese and western drugses of duration of test.
3, three months is a course of treatment.
Observed result
The sick kind | The example number | Be almost recovered | % | Produce effects | ?% | Effectively | ?% | Invalid | ??% | Total effective rate |
Cerebral thrombosis | 66 | ?20 | ?31.8 | ?20 | 31.8 | ?24 | 36.3 | ?2 | ?1 | ?99% |
Cerebral hemorrhage | 27 | ??8 | ?29.6 | ??4 | 14.8 | ?13 | 48 | ?2 | ?7.4 | ?93.6% |
Cerebral embolism | 7 | ??2 | ?28.5 | ??2 | 28.5 | ?2 | 28.5 | ?1 | ?14.2 | ?85.8% |
Discuss
1, this strain pure Chinese medicinal preparation is used for 100 routine patients, except that 5 examples are invalid, does not have any untoward reaction.
2, all react general 1-2 and can recover the course of treatment through following up a case by regular visits to patient and patient letter, determined curative effect, taking convenience is a kind of Chinese medicine preparation that is worthy to be popularized.
3, this medicine clinical practice, limbs have in various degree heating, pain, formication mostly in a short time, are that this symptom can be recovered without treatment due to the drug effect.
Can find out that according to above-mentioned material the clinical effective rate of this Chinese patent medicine can reach 95%, be higher than the mean level of present treatment primary disease, and toxic and side effects is little, determined curative effect, low price, taking convenience.
The raw material of Chinese medicine weight proportion following (b is Unit Weight part) that 1 example of embodiment adopts
Radix Astragali 140b Ramulus Uncariae Cum Uncis 55b Scorpio 10b
Scolopendra 10b Radix Rehmanniae 30b Radix Paeoniae Rubra 20b
Radix Salviae Miltiorrhizae 85b Flos Carthami 30b Pheretima 33b
Flos Chrysanthemi 30b Rhizoma Gastrodiae 4b Poria 55b
Rhizoma Atractylodis Macrocephalae 20b Ramulus Mori 55b Radix Glycyrrhizae 20b
Fructus Corni 20b Rhizoma Dioscoreae 55b Cortex Moutan 20b
This routine manufacture method of the orange 55b Moschus of Radix Scutellariae 11b 0.0004b is as follows: 1, get the Chinese herbal medicine of respectively distinguishing the flavor of by above-mentioned weight proportion; 2, be ground into fine powder, sieve, mixing; 3, every 100g powder adds 80-110g Mel, stirs, and one-tenth sticks together, and shaping is made the 9g big honeyed pills.Usage and consumption: oral, every day secondary, each half ball, warm yellow wine send down, and is each
Join yellow wine 10ml treatment time: taboo in three months and attention: period in a medicine is avoided tobacco and wine and oils and fats food, prevents direct stimulation, mistake
Degree is sad, fierceness and strenuous exercise.The raw material of Chinese medicine weight proportion following (b is Unit Weight part) that embodiment 2, this example adopt
Radix Astragali 100b Ramulus Uncariae Cum Uncis 35b Scorpio 8b
Scolopendra 8b Radix Rehmanniae 24b Radix Paeoniae Rubra 16b
Radix Salviae Miltiorrhizae 65b Flos Carthami 24b Pheretima 27b
Flos Chrysanthemi 24b Rhizoma Gastrodiae 2b Poria 35b
Rhizoma Atractylodis Macrocephalae 16b Ramulus Mori 35b Radix Glycyrrhizae 16b
Fructus Corni 16b Rhizoma Dioscoreae 35b Cortex Moutan 16b
The orange 35b Moschus of Radix Scutellariae 11b 0.0002b makes honeyed pill with above-mentioned raw material of Chinese medicine with conventional method.
The raw material of Chinese medicine weight proportion following (b is Unit Weight part) that embodiment 3, this example adopt
Radix Astragali 120b Ramulus Uncariae Cum Uncis 45b Scorpio 9b Scolopendra 9b
Radix Rehmanniae 27b Radix Paeoniae Rubra 18b Radix Salviae Miltiorrhizae 75b Flos Carthami 27b
Pheretima 30b Flos Chrysanthemi 27b Rhizoma Gastrodiae 3b Poria 45b
Rhizoma Atractylodis Macrocephalae 18b Ramulus Mori 45b Radix Glycyrrhizae 18b Fructus Corni 18b
The orange 45b of Rhizoma Dioscoreae 45b Cortex Moutan 18b Radix Scutellariae 9b
Moschus 0.0003b Concha Haliotidis 60b Radix Gentianae 9b Radix Angelicae Sinensis 30b
Bungarus Parvus 1b Spica Prunellae 27b
Rhizoma pinelliae cordatae 36b Rhizoma Arisaematis 27b Fructus Aurantii Immaturus 27b Caulis Bambusae In Taenia 45b
Radix Puerariae 36b Radix Aristolochiae Fangchi 27b Rhizoma Typhonii 27b Fructus Lycii 18b
Radix Rehmanniae Preparata 27b Rhizoma Alismatis 18b
This example adds the Radix Angelicae Sinensis promoting the circulation of blood dissipating blood stasis of invigorating blood circulation again on the main formula basis, the Bungarus Parvus dredge the meridian passage that relieves dizziness, high fever, infantile convulsions, epilepsy, etc., Concha Haliotidis, Spica Prunellae, Rhizoma Typhonii suppressing the hyperactive liver and subsiding YANG dispel the wind, Radix Stephaniae Tetrandrae spleen invigorating eliminating dampness and dredging channels, Fructus Lycii, Radix Rehmanniae Preparata, Rhizoma Alismatis nourishing the kidney and liver yin fluid astringing, Radix Gentianae, Caulis Bambusae In Taenia, Radix Puerariae, Rhizoma pinelliae cordatae, Rhizoma Arisaematis, Fructus Aurantii Immaturus heat clearing and damp drying are reduced phlegm.
The raw material of Chinese medicine of said ratio is made honeyed pill by embodiment 1 described method.
Claims (2)
1, the Chinese patent medicine compound recipe hemiplegia recovery ball of treatment hemiplegia is characterized in that, it is (b is Unit Weight part) that this Chinese patent medicine adopts the weight proportion of raw material of Chinese medicine
Radix Astragali 100-140b Ramulus Uncariae Cum Uncis 35-55b Scorpio 8-10b
Scolopendra 8-10b Radix Rehmanniae 24-30b Radix Paeoniae Rubra 16-20b
Radix Salviae Miltiorrhizae 65-85b Flos Carthami 24-30b Pheretima 27-33b
Flos Chrysanthemi 24-30b Rhizoma Gastrodiae 2-4b Poria 35-55b
Rhizoma Atractylodis Macrocephalae 16-20b Ramulus Mori 35-55b Radix Glycyrrhizae 16-20b
Fructus Corni 16-20b Rhizoma Dioscoreae 35-55b Cortex Moutan 16-20b
The orange 35-55b of Radix Scutellariae 7-11b
Moschus 0.0002-0.0004b
Above-mentioned Chinese medicine raw materials by weight proportion is made oral administration pills.
2, the Chinese patent medicine compound recipe hemiplegia recovery ball of treatment hemiplegia according to claim 1 is characterized in that, it is (b is unit weight part) that this medicine adopts the weight proportion of raw material of Chinese medicine
Radix Astragali 120b Ramulus Uncariae Cum Uncis 45b Scorpio 9b Scolopendra 9b
Radix Rehmanniae 27b Radix Paeoniae Rubra 18b Radix Salviae Miltiorrhizae 75b Flos Carthami 27b
Pheretima 30b Flos Chrysanthemi 27b Rhizoma Gastrodiae 3b Poria 45b
Rhizoma Atractylodis Macrocephalae 18b Ramulus Mori 45b Radix Glycyrrhizae 18b Fructus Corni 18b
The orange 45b of Rhizoma Dioscoreae 45b Cortex Moutan 18b Radix Scutellariae 9b
Moschus 0.0003b Concha Haliotidis 60b Radix Gentianae 9b Radix Angelicae Sinensis 30b
Bungarus Parvus 1b Spica Prunellae 27b
Rhizoma pinelliae cordatae 36b Rhizoma Arisaematis 27b Fructus Aurantii Immaturus 27b Caulis Bambusae In Taenia 45b
Radix Puerariae 36b Radix Aristolochiae Fangchi 27b Rhizoma Typhonii 27b Fructus Lycii 18b
Radix Rehmanniae Preparata 27b Rhizoma Alismatis 18b
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of honeyed pill dosage form.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95117933A CN1055220C (en) | 1995-11-02 | 1995-11-02 | Chinese drug for treatment of hemiplegia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95117933A CN1055220C (en) | 1995-11-02 | 1995-11-02 | Chinese drug for treatment of hemiplegia |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1132096A true CN1132096A (en) | 1996-10-02 |
CN1055220C CN1055220C (en) | 2000-08-09 |
Family
ID=5081466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95117933A Expired - Fee Related CN1055220C (en) | 1995-11-02 | 1995-11-02 | Chinese drug for treatment of hemiplegia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1055220C (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1072497C (en) * | 1998-06-07 | 2001-10-10 | 黄海峰 | Medicine for treating hemiplegia and preparation method thereof |
CN104225275A (en) * | 2014-09-09 | 2014-12-24 | 青岛市市立医院 | Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method of composition |
CN104740363A (en) * | 2015-03-20 | 2015-07-01 | 鄢明亮 | Traditional Chinese medicine preparation for treating apoplectic hemiplegia and preparation method |
CN105288225A (en) * | 2014-07-13 | 2016-02-03 | 胡培芹 | Chinese patent medicines for treating cerebral palsy |
CN114504635A (en) * | 2022-04-08 | 2022-05-17 | 邓山松 | Chinese patent medicine for treating apoplexy sequela |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1074374A (en) * | 1992-11-28 | 1993-07-21 | 吕汇川 | Hemiplegia recovery oral liquid and compound method |
CN1092666A (en) * | 1993-03-19 | 1994-09-28 | 杨诗琴 | A kind of hypotensive palsy-treating preparation and preparation method thereof |
CN1104910A (en) * | 1994-06-09 | 1995-07-12 | 李全海 | Medicinal liquor for hemiparalysis |
CN1106674A (en) * | 1994-10-13 | 1995-08-16 | 汪志伟 | Traditional Chinese medicine for curing paralysis |
-
1995
- 1995-11-02 CN CN95117933A patent/CN1055220C/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1072497C (en) * | 1998-06-07 | 2001-10-10 | 黄海峰 | Medicine for treating hemiplegia and preparation method thereof |
CN105288225A (en) * | 2014-07-13 | 2016-02-03 | 胡培芹 | Chinese patent medicines for treating cerebral palsy |
CN104225275A (en) * | 2014-09-09 | 2014-12-24 | 青岛市市立医院 | Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method of composition |
CN104740363A (en) * | 2015-03-20 | 2015-07-01 | 鄢明亮 | Traditional Chinese medicine preparation for treating apoplectic hemiplegia and preparation method |
CN114504635A (en) * | 2022-04-08 | 2022-05-17 | 邓山松 | Chinese patent medicine for treating apoplexy sequela |
CN114504635B (en) * | 2022-04-08 | 2023-03-14 | 邓山松 | Chinese patent medicine for treating apoplexy sequela |
Also Published As
Publication number | Publication date |
---|---|
CN1055220C (en) | 2000-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1169541C (en) | Medicine for treating rheumatoid arthritis | |
CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
CN1857541A (en) | Plaster for treating rheumatism and osteoarthrosis | |
CN1485083A (en) | Capsule for thyroid cancer / tumor and lymph node | |
CN1286518C (en) | Chinese medicinal prescription for treating gastropathy | |
CN1390585A (en) | Chinese medicine for detoxication purpose and its preparing process | |
CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
CN1218721C (en) | Chinese medicine proprietary for treating cerebrovascular and cardiovascular disease | |
CN102335336A (en) | Traditional Chinese medicine for treating lupus sebaceus | |
CN1055220C (en) | Chinese drug for treatment of hemiplegia | |
CN1237443A (en) | Medicine for curing rheumatic heart disease | |
CN1814208A (en) | Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis | |
CN105213766B (en) | A kind of dredging collateral supports knee soup and preparation method thereof | |
CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
CN1285354C (en) | Medicine for treating cerebral infarction | |
CN1310014A (en) | Lumbago treating Chinese medicine | |
CN1086586C (en) | Medicine for treating cardiac and cerebral vascular diseases and its preparation | |
CN1200724C (en) | Pill for activating collateral flow and removing spur | |
CN104147570A (en) | Traditional Chinese medicine preparation for treating children with iron deficiency anemia | |
CN1308025C (en) | Medicine for treating paraplegia and its preparing method | |
CN1186074C (en) | Chinese medicinal proprietary for treating hemiplegic by apoplexia-Fuzhengpiantanwan | |
CN1515284A (en) | Rongshuan jiannaokang thrombolytic | |
CN1342478A (en) | Medical wine for treating rheumatism | |
CN1241602C (en) | Oral administered medicated wine for treating cardiovascular and cerebrovascular diseases | |
CN1051018C (en) | Health bag for stomach and kidney |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1032833 Country of ref document: HK |
|
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |